Skip to main content

Animations

MJFF Publications

5371 - 5380 of 6258 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2025
  • 2022
  • 2021
  • 2016
  • 2021
  • 2021
  • 2014
  • 2020
  • Summary Details
    OPEN
    Title: A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51280
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Deep Learning Identifies Digital Biomarkers for Self-Reported Parkinson's Disease
    Journal Name: Patterns
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.patter.2020.100042
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Neurophysiological gradient in the Parkinsonian subthalamic nucleus as a marker for motor symptoms and apathy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00848-2
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105885
    Citation Count: 11
  • Summary Details
    OPEN
    Title: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28706
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Cross‐validation of optimized composites for preclinical Alzheimer's disease
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.trci.2016.12.001
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100113
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-021-00892-7
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microglia
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa401
    Citation Count: 44
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.